Macrogen Inc
KOSDAQ:038290
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Macrogen Inc
Free Cash Flow
Macrogen Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Macrogen Inc
KOSDAQ:038290
|
Free Cash Flow
-₩32.9B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-24%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Free Cash Flow
₩772.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Free Cash Flow
-₩5.2B
|
CAGR 3-Years
-99%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Free Cash Flow
-₩23.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Free Cash Flow
-₩33.3B
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Free Cash Flow
-₩130.6B
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-31%
|
|
Macrogen Inc
Glance View
Macrogen, Inc. engages in the provision genetic research and biotechnology services. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-02-22. The firm operates its business through four divisions: deoxyribonucleic acid (DNA) sequencing division, DNA chips division, transgenic and knockout mouse division and oligonucleotide DNA division. Its DNA sequencing division provides genome sequencing analysis services. Its DNA chips division develops DNA chips products, such as Illumina chips, MacArray chips and customized chips. Its transgenic and knockout mouse division offers gene engineering services. Its oligonucleotide DNA division offers oligonucleotide DNA manufacturing services. The firm operates its business within domestic market and in overseas markets.
See Also
What is Macrogen Inc's Free Cash Flow?
Free Cash Flow
-32.9B
KRW
Based on the financial report for Sep 30, 2025, Macrogen Inc's Free Cash Flow amounts to -32.9B KRW.
What is Macrogen Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-24%
Over the last year, the Free Cash Flow growth was -62%. The average annual Free Cash Flow growth rates for Macrogen Inc have been -45% over the past three years , -7% over the past five years , and -24% over the past ten years .
